HuGE Literature Finder
Records
1
-
2
Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer. Endocrine 2016 Oct . Latteyer Soeren, Tiedje Vera, König Katharina, Ting Saskia, Heukamp Lukas C, Meder Lydia, Schmid Kurt Werner, Führer Dagmar, Moeller Lars Christi |
Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation. Diagnostic pathology 2016 Feb 11 21. Bae Ja Seong, Kim Yourha, Jeon Sora, Kim Se Hee, Kim Tae Jung, Lee Sohee, Kim Min-Hee, Lim Dong Jun, Lee Youn Soo, Jung Chan Kw |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: